Ting-Ting Qiao1, Wei Zheng2, Wei Xing1, Li-Xia Zhang1, Wei Zhang1, Yan-Ping Shi1, Xiao-Juan Chen1. 1. The Second Affiliated Hospital of Zhengzhou University, No. 2, Jingba Road , Jingshui District, Zhengzhou, Henan Province, 450000, China. 2. The Second Affiliated Hospital of Zhengzhou University, No. 2, Jingba Road , Jingshui District, Zhengzhou, Henan Province, 450000, China. zw112689zy@sina.com.
Abstract
PURPOSE: This study aimed to translate, culturally adapt, and test the psychometric properties of the Reproductive Concerns After Cancer scale (RCAC) in young Chinese female cancer survivors. METHODS: The Chinese version of the RCAC was developed using the standard Functional Assessment of Chronic Illness Therapy (FACIT) translation methodology, and then 800 young Chinese female cancer survivors were recruited to complete the scale. The validation of the RCAC is as follows: (1) content validity was evaluated by a group of experts; (2) factor structure was assessed using confirmatory factor analysis and factorial invariance analysis; (3) convergent validity was determined by correlations with the Patient Health Questionnaire 9 (PHQ-9) and Functional Assessment of Cancer Therapy-General (FACT-G) scale; (4) internal consistency reliability was assessed using Cronbach's α coefficient; and (5) test-retest reliability was assessed using intra-class correlations. RESULTS: Internal consistency (Cronbach's alpha coefficients ranged from 0.71 to 0.81) and test-retest reliability (intra-class correlation coefficients ranged from 0.82 to 0.95) of the Chinese version of the RCAC were satisfactory. Results also indicated that the content validity index of the RCAC (Chinese version) was good. The Chinese version of the RCAC score was correlated with the PHQ-9 (r = 0.568, p < 0.01) and FACT-G (r = -0.524, p < 0.01) scores, which indicated acceptable convergent validity. Confirmatory factor analysis supported a six-factor structure of the Chinese version of the RCAC with a good model fit. Moreover, multi-group confirmatory factor analysis indicated factorial invariance (configural, metric, scalar, and strict invariance) of the RCAC across cancer types. CONCLUSIONS: The translation and cross-cultural adaption of the RCAC into Chinese was successful. The Chinese version of the RCAC has suitable factor structure and psychometric properties for reproductive concerns evaluation in young female cancer patients and is appropriate to use in clinical trials of Chinese patients.
PURPOSE: This study aimed to translate, culturally adapt, and test the psychometric properties of the Reproductive Concerns After Cancer scale (RCAC) in young Chinese female cancer survivors. METHODS: The Chinese version of the RCAC was developed using the standard Functional Assessment of Chronic Illness Therapy (FACIT) translation methodology, and then 800 young Chinese female cancer survivors were recruited to complete the scale. The validation of the RCAC is as follows: (1) content validity was evaluated by a group of experts; (2) factor structure was assessed using confirmatory factor analysis and factorial invariance analysis; (3) convergent validity was determined by correlations with the Patient Health Questionnaire 9 (PHQ-9) and Functional Assessment of Cancer Therapy-General (FACT-G) scale; (4) internal consistency reliability was assessed using Cronbach's α coefficient; and (5) test-retest reliability was assessed using intra-class correlations. RESULTS: Internal consistency (Cronbach's alpha coefficients ranged from 0.71 to 0.81) and test-retest reliability (intra-class correlation coefficients ranged from 0.82 to 0.95) of the Chinese version of the RCAC were satisfactory. Results also indicated that the content validity index of the RCAC (Chinese version) was good. The Chinese version of the RCAC score was correlated with the PHQ-9 (r = 0.568, p < 0.01) and FACT-G (r = -0.524, p < 0.01) scores, which indicated acceptable convergent validity. Confirmatory factor analysis supported a six-factor structure of the Chinese version of the RCAC with a good model fit. Moreover, multi-group confirmatory factor analysis indicated factorial invariance (configural, metric, scalar, and strict invariance) of the RCAC across cancer types. CONCLUSIONS: The translation and cross-cultural adaption of the RCAC into Chinese was successful. The Chinese version of the RCAC has suitable factor structure and psychometric properties for reproductive concerns evaluation in young female cancerpatients and is appropriate to use in clinical trials of Chinese patients.
Authors: Mir Saeed Yekaninejad; Amir H Pakpour; Jyothi Tadakamadla; Santhosh Kumar; Seyed Hamzeh Mosavi; Bengt Fridlund; Andrew Bottomley; Neil K Aaronson Journal: Support Care Cancer Date: 2014-10-15 Impact factor: 3.603
Authors: Lari Wenzel; Aysun Dogan-Ates; Rana Habbal; Ross Berkowitz; Donald P Goldstein; Marilyn Bernstein; Brenda Coffey Kluhsman; Kathryn Osann; Edward Newlands; Michael J Seckl; Barry Hancock; David Cella Journal: J Natl Cancer Inst Monogr Date: 2005
Authors: Jayeon Kim; Jennifer E Mersereau; H Irene Su; Brian W Whitcomb; Vanessa L Malcarne; Jessica R Gorman Journal: Support Care Cancer Date: 2016-03-04 Impact factor: 3.603
Authors: Katie Young; Ksenya Shliakhtsitsava; Loki Natarajan; Emily Myers; Andrew C Dietz; Jessica R Gorman; María Elena Martínez; Brian W Whitcomb; H Irene Su Journal: Cancer Date: 2018-11-29 Impact factor: 6.860
Authors: Belinda Rina Marie Spagnoletti; Linda Rae Bennett; Christina Keenan; Suman Surendra Shetty; Lenore Manderson; Barbara McPake; Siswanto Agus Wilopo Journal: Reprod Health Date: 2022-03-19 Impact factor: 3.223
Authors: Pan Pan Xiao; Si Qing Ding; Ying Long Duan; Xiao Fei Luo; Yi Zhou; Qin Qin Cheng; Xiang Yu Liu; Jian Fei Xie; Andy Sk Cheng Journal: Front Psychol Date: 2022-09-27